American Shared Hospital Services Stock Earnings Reports

Key points for investors: Management change — Gary Delanois stepped down as CEO and Craig Tagawa (longtime executive) was named Interim CEO. Financial performance — Q1 2026 revenue rose ~15.9% year‑over‑year to $7.1M, driven by Direct Patient Care Services; adjusted EBITDA increased ~18.4% to $1.1M while net loss narrowed to $0.6M ($0.09/share). Volume drivers — higher procedure volumes at Rhode Island centers, the Puebla (Mexico) center and growth in proton beam therapy (fractions +20% YoY). Segment mix — Direct Patient Services growing rapidly (Direct revenue up ~30.2%); leasing revenue stable. Operations & growth pipeline — ongoing ramp of newer centers, international expansion (Guadalajara expected late 2026) and Rhode Island projects (Bristol RT center in ~18–24 months; Johnston proton facility ~24–30 months). Balance sheet/liquidity — cash improved to ~$5.2M at quarter end (from $3.7M), some cash repatriated from international operations; current portion of long‑term debt ~$16.8M. Banking — productive discussions with lender regarding potential extension; previously out of compliance on cash but cash has recovered above the $5M level. Risks/notes — continued near‑term investment and higher fixed costs from ramping centers keep net loss; comparisons affected by a prior‑year contract expiration (and a two‑year extension for a related agreement was signed). Overall tone — management is focused on increasing utilization, margin expansion, operational execution and believes the business is undervalued with meaningful longer‑term growth opportunities.